traumatic amputation
Recently Published Documents


TOTAL DOCUMENTS

206
(FIVE YEARS 47)

H-INDEX

18
(FIVE YEARS 2)

Author(s):  
Pena Acevedo L ◽  
◽  
Rodriguez Pena S ◽  

A 30-year-old man developed secondary osteomyelitis after a traumatic amputation of his right index finger. The infection was treated with ciprofloxacin. Approximately 4 weeks after starting treatment, he complained of a progressive decrease in visual acuity, retro-ocular pain and bitemporal headache. A diagnosis of intracranial hypertension was established. Blood sample analysis, infectious profile, cerebrospinal fluid analysis, and neuroimaging were normal. Visual acuity and other symptoms progressively improved after stopping drug treatment. There were no complications or sequelae. Intracranial hypertension due to fluoroquinolones is described in the medical literature, its appearance during such treatments, despite being a rare adverse event, should be monitored.


BMJ Open ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. e049533
Author(s):  
Cornelia Anne Barth ◽  
Andreas Wladis ◽  
Catherine Blake ◽  
Prashant Bhandarkar ◽  
Sigirya Aebischer Perone ◽  
...  

ObjectivesLimb amputation incidence is particularly high in fragile contexts due to conflict, accidents and poorly managed diabetes. The study aim was to analyse (1) demographic and amputation characteristics of persons with any type of acquired amputation (PwA) and (2) time between amputation and first access to rehabilitation in five conflict and postconflict countries.DesignA retrospective, observational study analysing differences in demographic and clinical factors and time to access rehabilitation between users with traumatic and non-traumatic amputations.SettingFive countries with the highest numbers of PwA in the global International Committee of the Red Cross database (Afghanistan, Cambodia, Iraq, Myanmar, Sudan). Cleaned and merged data from 2009 to 2018 were aggregated by sex; age at amputation and registration; cause, combination and anatomical level of amputation(s); living environment.ParticipantsAll PwA newly attending rehabilitation.ResultsData for 28 446 individuals were included (4329 (15.2%) female). Most were traumatic amputations (73.4%, 208 90); of these, 48.6% (138 01) were conflict related. Average age at traumatic amputation for men and women was 26.9 and 24.1 years, respectively; for non-traumatic amputation it was 49.1 years and 45.9 years, respectively. Sex differences in age were statistically significant for traumatic and non-traumatic causes (p<0.001, p=0.003). Delay between amputation and rehabilitation was on average 8.2 years for those with traumatic amputation, significantly higher than an average 3 years for those with non-traumatic amputation (p<0.001).ConclusionsYoung age for traumatic and non-traumatic amputations indicates the devastating impact of war and fragile health systems on a society. Long delays between amputation and rehabilitation reveal the mismatch of needs and resources. For rehabilitation service providers in fragile settings, it is an enormous task to manage the diversity of PwA of various causes, age, sex and additional conditions. Improved collaboration between primary healthcare, surgical and rehabilitation services, a prioritisation of rehabilitation and increased resource provision are recommended to ensure adequate access to comprehensive rehabilitation care for PwA.


Author(s):  
K.G. Akakpo-Numado ◽  
T.E. Kouevi-Koko ◽  
Amouzou Ks ◽  
Dare S ◽  
Edoh-Bedi Lyna ◽  
...  
Keyword(s):  

2021 ◽  
Vol 2021 ◽  
pp. 1-3
Author(s):  
Gregory M. Halenda ◽  
Stylianos Voulgarelis

Liposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic in children older than the age of six. Despite this recently expanded indication, the literature lacks reports of use for peripheral nerve blockade in children. We describe a case where liposomal bupivacaine was used for femoral and sciatic nerve blocks in a 5-year-old child with traumatic amputation of his lower leg. Pain control was excellent, with no pain or opioid use reported during the first 62 hours. After the regional anesthesia subsided, the patient required in total 4 oral doses of oxycodone 0.1 mg/kg prior to discharge. The patient did not develop chronic pain or phantom limb syndrome. While liposomal bupivacaine is not currently FDA-approved for peripheral nerve blockade in children, this case highlights a potentially effective use of this drug and possible area for further investigation.


The Lancet ◽  
2021 ◽  
Vol 398 ◽  
pp. S30
Author(s):  
Hanne Heszlein-Lossius ◽  
Anas Ismail ◽  
Yahya Al-Borno ◽  
Samar Shaqqoura ◽  
Nashwa Skaik ◽  
...  

Author(s):  
Iain A. Rankin ◽  
Thuy-Tien Nguyen ◽  
Louise McMenemy ◽  
Jonathan C. Clasper ◽  
Spyros D. Masouros

Traumatic amputation has been one of the most defining injuries associated with explosive devices. An understanding of the mechanism of injury is essential in order to reduce its incidence and devastating consequences to the individual and their support network. In this study, traumatic amputation is reproduced using high-velocity environmental debris in an animal cadaveric model. The study findings are combined with previous work to describe fully the mechanism of injury as follows. The shock wave impacts with the casualty, followed by energised projectiles (environmental debris or fragmentation) carried by the blast. These cause skin and soft tissue injury, followed by skeletal trauma which compounds to produce segmental and multifragmental fractures. A critical injury point is reached, whereby the underlying integrity of both skeletal and soft tissues of the limb has been compromised. The blast wind that follows these energised projectiles completes the amputation at the level of the disruption, and traumatic amputation occurs. These findings produce a shift in the understanding of traumatic amputation due to blast from a mechanism predominately thought mediated by primary and tertiary blast, to now include secondary blast mechanisms, and inform change for mitigative strategies.


2021 ◽  
Vol 4 (2) ◽  
pp. e2036297
Author(s):  
Jessica I. Billig ◽  
Jacob S. Nasser ◽  
Hoyune E. Cho ◽  
Ching-Han Chou ◽  
Kevin C. Chung

Sign in / Sign up

Export Citation Format

Share Document